Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-17-002158

Director bought 2,222,222 shares at $2.70 ($5,999,999)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS, L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-02-15 Purchase : show line 1 in the form +2,222,222 $2.70 $5,999,999 27,119,254 D
2017-02-15 Purchase : show line 2 in the form +0 27,119,254 I
Open-market purchases · 2,222,222 sh · avg $2.70 · $5,999,999
Loading xslF345X03/p7416080.xml…